ZRANB2 and hepatocellular carcinoma: ZRANB2 was upregulated by 2.11-fold changes in 374 hepatocellular carcinoma tissues compared with 50 normal samples, as revealed by ENCORI database (P = 9.9e − 21, Figure 4(a)).